Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease

Chutintorn SriphrapradangFaculty of Medicine Ramathibodi Hospital, Mahidol University2022-08-042022-08-042021-11-01Endocrine. Vol.74, No.2 (2021), 226-227155901001355008X2-s2.0-85115108725https://repository.li.mahidol.ac.th/handle/123456789/75987Mahidol UniversityBiochemistry, Genetics and Molecular BiologyMedicineAggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ diseaseLetterSCOPUS10.1007/s12020-021-02879-8